What's breaking now, across thousands of outlets.
Kobayashi Pharmaceutical Co., the Japanese health products company that was at the center of a supplement contamination scandal involving suspected deaths, is said to be considering a potential buyout offer of more than ¥500 billion ($3.2 billion) by private equity investors.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
Key PointsThere's a misconception that higher rates are bad for U.S. stocks.
EUR/CAD gains ground after registering modest losses the previous day, trading around 1.6060 during European hours on Thursday.
Silver price (XAG/USD) is down 1.25% to near $63.60 during the European trading session on Thursday. The white metal faces intense selling pressure after hawkish remarks from New York Federal Reserve…
Les taux d’intérêt mondiaux à travers le monde sont au plus haut, à des niveaux inédits depuis vingt ans, au point que certains redoutent aujourd’hui une crise de la dette.
<p>Doha, Qatar: The price of gold in the Qatari market declined by 2.16 percent during the current week, reaching $4,284.63670 per ounce on Thursday, according to data issued by Qatar National Bank…
The stock market came under heavy selling pressure, with the Sensex and Nifty declining nearly 1.5% as a sharp rise in bond yields to 19-year highs added to investor concerns.
